TACL
Therapeutic Advances in Childhood Leukemia & Lymphoma
Log in
T2009-012 (Panobinostat)
Protocol Opened: March 21, 2011
Protocol Chair: Julio Barredo, M.D.
Protocol Vice-Chair: Maria Luisa Sulis, M.D.
T2009-012 Protocol Amendment #5 (clean)
T2009-012 Protocol Amendment #5 (tracked)
Amendment #5 Summary of Changes
Amendment #5 Sample Consent
FDA IND Study May Proceed Letter
Research Monitoring Plan
Amendments
CRFs and Roadmaps
Data Safety and Monitoring Progress Reports